1. Home
  2. EOLS vs EGY Comparison

EOLS vs EGY Comparison

Compare EOLS & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • EGY
  • Stock Information
  • Founded
  • EOLS 2012
  • EGY 1985
  • Country
  • EOLS United States
  • EGY United States
  • Employees
  • EOLS N/A
  • EGY N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • EGY Oil & Gas Production
  • Sector
  • EOLS Health Care
  • EGY Energy
  • Exchange
  • EOLS Nasdaq
  • EGY Nasdaq
  • Market Cap
  • EOLS 787.7M
  • EGY 649.4M
  • IPO Year
  • EOLS 2018
  • EGY N/A
  • Fundamental
  • Price
  • EOLS $12.11
  • EGY $5.26
  • Analyst Decision
  • EOLS Strong Buy
  • EGY Strong Buy
  • Analyst Count
  • EOLS 6
  • EGY 1
  • Target Price
  • EOLS $22.60
  • EGY $8.00
  • AVG Volume (30 Days)
  • EOLS 672.0K
  • EGY 810.1K
  • Earning Date
  • EOLS 11-06-2024
  • EGY 11-11-2024
  • Dividend Yield
  • EOLS N/A
  • EGY 4.75%
  • EPS Growth
  • EOLS N/A
  • EGY 170.05
  • EPS
  • EOLS N/A
  • EGY 0.86
  • Revenue
  • EOLS $248,326,000.00
  • EGY $506,421,000.00
  • Revenue This Year
  • EOLS $33.57
  • EGY $4.66
  • Revenue Next Year
  • EOLS $32.91
  • EGY N/A
  • P/E Ratio
  • EOLS N/A
  • EGY $6.09
  • Revenue Growth
  • EOLS 34.42
  • EGY 25.82
  • 52 Week Low
  • EOLS $9.00
  • EGY $4.03
  • 52 Week High
  • EOLS $17.82
  • EGY $7.51
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 26.80
  • EGY 36.77
  • Support Level
  • EOLS $16.12
  • EGY $5.19
  • Resistance Level
  • EOLS $17.44
  • EGY $5.88
  • Average True Range (ATR)
  • EOLS 0.75
  • EGY 0.20
  • MACD
  • EOLS -0.48
  • EGY -0.01
  • Stochastic Oscillator
  • EOLS 12.19
  • EGY 10.14

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea and Corporate and Other. The company generates maximum revenue from the Gabon segment.

Share on Social Networks: